,

Prucomed 2

Prucomed 2 Composition:

  • Prucalopride Succinate equivalent to Prucalopride 2 mg
    Therapeutic Class:

  • Gastroprokinetic / Chronic Constipation Treatment
    Schedule: Schedule H (Prescription Only)

Prucomed 2 is a selective serotonin 5-HT₄ receptor agonist used in the treatment of chronic idiopathic constipation (CIC). Unlike laxatives, Prucalopride acts directly on gut motility to restore natural bowel movement, providing a mechanistic solution for patients with long-term, unresolved constipation.

Usage of Prucomed 2

Prucomed 2 is indicated for:

  • Chronic idiopathic constipation (CIC) in adults, particularly where laxatives have failed

  • Constipation associated with irritable bowel syndrome (IBS-C) (off-label use in some regions)

  • Useful in elderly or bedridden patients with slow colonic transit


Mechanism of Action

Prucalopride is a highly selective 5-HT₄ receptor agonist that:

  • Stimulates colonic peristalsis

  • Accelerates gastrointestinal transit

  • Enhances frequency and completeness of spontaneous bowel movements

  • Has minimal cardiovascular risk compared to older 5-HT₄ agents (e.g., cisapride, tegaserod)


Key Benefits

Restores natural motility without dependence
✅ Effective in laxative-refractory constipation
✅ Reduces symptoms like straining, bloating, and incomplete evacuation
✅ Safe for long-term use
✅ Improves quality of life and bowel satisfaction scores


Common Side Effects

  • Headache (most common)

  • Nausea

  • Abdominal pain or cramping

  • Diarrhea (transient)

  • Dizziness, flatulence (less frequent)

Most side effects are mild and occur during the first days of treatment.


Precautions

  • Not recommended in patients with:

    • Intestinal perforation or obstruction

    • Severe inflammatory bowel disease

    • End-stage renal disease without dialysis

  • Monitor for severe persistent diarrhea

  • Use cautiously in patients with a history of arrhythmia or cardiovascular disease


Drug Interactions

  • Minimal CYP450 interaction — low risk of drug-drug interactions

  • Can be safely co-administered with PPIs, H2 blockers, and iron supplements

  • Avoid with potent P-gp inhibitors in renal impairment

  • Alcohol may worsen GI side effects


Dosage and Administration

  • Adult dose: 2 mg once daily, orally, with or without food

  • Elderly (>65 yrs): Start with 1 mg once daily (may increase to 2 mg if needed)

  • If no improvement after 4 weeks, consider discontinuation


Storage

  • Store below 25°C, protected from moisture

  • Keep out of reach of children


Patient Counseling Points

  • Explain that this is not a laxative, but a motility enhancer

  • Relief may take a few days; do not expect immediate effect

  • Hydration and dietary fiber remain essential

  • Report symptoms like severe diarrhea or abdominal pain

  • Avoid self-escalating the dose

Review My Order

0

Subtotal